(VIANEWS) - iRadimed Corporation (IRMD), Alphabet (GOOG), United Therapeutics Corporation (UTHR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. iRadimed Corporation (IRMD)
46.8% sales growth and 13.97% return on equity
IRADIMED CORPORATION designs, produces, markets and distributes compatible magnetic resonance imaging (MRI), medical devices and accessories in the United States as well as internationally.
iRadimed Corporation's sales growth this year is expected to be 24.3% and 11% for next year.
Year-on-year quarterly revenue growth grew by 38.9%, now sitting on 41.81M for the twelve trailing months.
Volume
Today's last reported volume for iRadimed Corporation is 283693 which is 246.43% above its average volume of 81890.
iRadimed Corporation's sales growth for the next quarter is 46.8%. The company's growth estimates for the ongoing quarter and the next is 53.8% and 64.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.97%.
Volatility
iRadimed Corporation's last day, last week, and last month's current intraday variation average was 11.85%, 3.58%, and 3.16%, respectively.
iRadimed Corporation's highest amplitude of average volatility was 14.20% (day), 8.84% (last week), and 6.39% (last month), respectively.
iRadimed Corporation's Stock Yearly Top and Bottom Value
iRadimed Corporation's stock is valued at $52.20 at 06:22 EST, under its 52-week high of $54.73 and way higher than its 52-week low of $22.80.
iRadimed Corporation's Moving Average
iRadimed Corporation's value is way above its 50-day moving average of $45.50 and way higher than its 200-day moving average of $38.53.2. Alphabet (GOOG)
16.4% sales growth and 32.07% return on equity
Alphabet Inc. offers online advertising services throughout the United States, Europe and the Middle East.
Alphabet's sales growth this year is expected to be 18% and 15.6% for next year.
Year-on-year quarterly revenue growth grew by 32.4%, now sitting on 257.64B for the twelve trailing months.
Volume
Today's last reported volume for Alphabet is 148390 which is 90.33% below its average volume of 1535280.
Alphabet's sales growth for the next quarter is 16.4%. The company's growth estimates for the present quarter and the next is a negative 1.4% and 0.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 32.07%.
Volatility
Alphabet's last day, last week, and last month's current intraday variation average was 3.11%, 2.19%, and 1.86%, respectively.
Alphabet's highest amplitude of average volatility was 3.54% (day), 2.99% (last week), and 3.05% (last month), respectively.
Alphabet's Stock Yearly Top and Bottom Value
Alphabet's stock is valued at $2,681.84 at 06:22 EST, way under its 52-week high of $3,042.00 and way above its 52-week low of $2,010.73.
Alphabet's Moving Average
Alphabet's value is below its 50-day moving average of $2,698.79 and below its 200-day moving average of $2,759.56.Previous days news about Alphabet(GOOG)
- According to CNBC on Tuesday, 22 March, "The Nasdaq Composite was the relative outperformer, rising 2% asMeta Platforms, Amazon, Apple, Netflix and Google-parent Alphabet all closed higher."
- According to Bloomberg Quint on Tuesday, 22 March, "Alibaba Cloud, Amazon.com Inc.'s AWS, Alphabet Inc.'s Google Cloud and Microsoft Corp.'s Azure are among the large companies that will adopt the new chips, Nvidia said. "
- According to Benzinga on Tuesday, 22 March, "The Business Roundtable is a non-profit lobbyist association whose members are the chief executive officers of several major U.S. companies, including General Motors Co (NYSE: GM), Apple Inc. (NASDAQ: AAPL), Amazon.com Inc. (NASDAQ: AMZN) and Alphabet Inc. (NASDAQ: GOOG) (NASDAQ: GOOGL)."
3. United Therapeutics Corporation (UTHR)
11.2% sales growth and 12.94% return on equity
United Therapeutics Corporation is a biotechnology firm that develops and markets products for patients living with life-threatening and chronic diseases.
United Therapeutics Corporation's sales growth this year is expected to be 14.3% and 10.7% for next year.
Year-on-year quarterly revenue growth grew by 7.9%, now sitting on 1.69B for the twelve trailing months.
Volume
Today's last reported volume for United Therapeutics Corporation is 543014 which is 21.51% above its average volume of 446886.
United Therapeutics Corporation's sales growth for the next quarter is 11.2%. The company's growth estimates for the ongoing quarter and the next is 63.9% and 452.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.94%.
Volatility
United Therapeutics Corporation's last day, last week, and last month's current intraday variation average was 1.82%, 1.66%, and 2.08%, respectively.
United Therapeutics Corporation's highest amplitude of average volatility was 3.51% (day), 3.44% (last week), and 3.91% (last month), respectively.
United Therapeutics Corporation's Stock Yearly Top and Bottom Value
United Therapeutics Corporation's stock is valued at $181.20 at 06:22 EST, way under its 52-week high of $218.38 and way higher than its 52-week low of $158.38.
United Therapeutics Corporation's Moving Average
United Therapeutics Corporation's value is under its 50-day moving average of $192.14 and below its 200-day moving average of $193.82.4. Banco Latinoamericano de Comercio Exterior, S.A. (BLX)
8.7% sales growth and 6.18% return on equity
Banco Latinoamericano de Comercio Exterior S.A. is a multi-national bank that primarily finances foreign trade in Latin America, the Caribbean, and other parts of the world.
Banco Latinoamericano de Comercio Exterior, S.A.'s sales growth this year is anticipated to be 8.7% and a negative 0% for next year.
Year-on-year quarterly revenue growth grew by 15.9%, now sitting on 101.88M for the twelve trailing months.
Volume
Today's last reported volume for Banco Latinoamericano de Comercio Exterior, S.A. is 85045 which is 16.45% below its average volume of 101801.
Banco Latinoamericano de Comercio Exterior, S.A.'s sales growth for the next quarter is 8.7%. The company's growth estimates for the ongoing quarter and the next is 34.4% and 27.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.18%.
Banco Latinoamericano de Comercio Exterior, S.A.'s Stock Yearly Top and Bottom Value
Banco Latinoamericano de Comercio Exterior, S.A.'s stock is valued at $15.57 at 06:22 EST, way below its 52-week high of $19.33 and above its 52-week low of $14.30.
Banco Latinoamericano de Comercio Exterior, S.A.'s Moving Average
Banco Latinoamericano de Comercio Exterior, S.A.'s worth is under its 50-day moving average of $15.88 and under its 200-day moving average of $16.54.5. Medical Properties Trust (MPW)
7.2% sales growth and 8.32% return on equity
Medical Properties Trust, Inc. was a self-advised trust for real estate investments that was established in 2003 to purchase and develop net-leased hospitals.
Medical Properties Trust's sales growth this year is expected to be 7.4% and 7.4% for next year.
Year-on-year quarterly revenue growth grew by 22.8%, now sitting on 1.57B for the twelve trailing months.
Volume
Today's last reported volume for Medical Properties Trust is 5176780 which is 6.06% above its average volume of 4880560.
Medical Properties Trust's sales growth for the next quarter is 7.2%. The company's growth estimates for the present quarter and the next is 10.7% and 57.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.32%.
Volatility
Medical Properties Trust's last day, last week, and last month's current intraday variation average was 2.28%, 0.93%, and 1.30%, respectively.
Medical Properties Trust's highest amplitude of average volatility was 2.88% (day), 2.66% (last week), and 2.70% (last month), respectively.
Medical Properties Trust's Stock Yearly Top and Bottom Value
Medical Properties Trust's stock is valued at $20.15 at 06:22 EST, way under its 52-week high of $24.13 and higher than its 52-week low of $19.39.
Medical Properties Trust's Moving Average
Medical Properties Trust's worth is under its 50-day moving average of $21.91 and below its 200-day moving average of $21.17.6. Automatic Data Processing (ADP)
6.8% sales growth and 50.12% return on equity
Automatic Data Processing, Inc. offers cloud-based solutions for human capital management worldwide.
Automatic Data Processing's sales growth this year is expected to be 8.6% and 7.1% for next year.
Year-on-year quarterly revenue growth grew by 8.9%, now sitting on 15.7B for the twelve trailing months.
Volume
Today's last reported volume for Automatic Data Processing is 728380 which is 63.3% below its average volume of 1984900.
Automatic Data Processing's sales growth is a negative 0% for the present quarter and 6.8% for the next. The company's growth estimates for the current quarter and the next is 10.1% and 20%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 50.12%.
Volatility
Automatic Data Processing's last day, last week, and last month's current intraday variation average was 0.96%, 1.31%, and 1.10%, respectively.
Automatic Data Processing's highest amplitude of average volatility was 1.18% (day), 1.82% (last week), and 2.27% (last month), respectively.
Automatic Data Processing's Stock Yearly Top and Bottom Value
Automatic Data Processing's stock is valued at $218.85 at 06:22 EST, way under its 52-week high of $248.96 and way above its 52-week low of $184.85.
Automatic Data Processing's Moving Average
Automatic Data Processing's worth is higher than its 50-day moving average of $209.17 and above its 200-day moving average of $214.03.7. Methode Electronics (MEI)
5.4% sales growth and 12.91% return on equity
Methode Electronics, Inc. manufactures, markets, and designs component and subsystem device worldwide.
Methode Electronics's sales growth this year is anticipated to be 7.3% and 4.2% for next year.
Year-on-year quarterly revenue growth declined by 1.3%, now sitting on 1.18B for the twelve trailing months.
Volume
Today's last reported volume for Methode Electronics is 183597 which is 5.47% below its average volume of 194232.
Methode Electronics's sales growth for the next quarter is 5.4%. The company's growth estimates for the current quarter and the next is 2.5% and 13.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.91%.
Volatility
Methode Electronics's last day, last week, and last month's current intraday variation average was 1.66%, 1.10%, and 1.64%, respectively.
Methode Electronics's highest amplitude of average volatility was 2.51% (day), 2.56% (last week), and 3.00% (last month), respectively.
Methode Electronics's Stock Yearly Top and Bottom Value
Methode Electronics's stock is valued at $43.44 at 06:22 EST, way below its 52-week high of $50.20 and way above its 52-week low of $39.03.